NCT07287943

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Efficacy and Safety of Medtronic 780G Automated Insulin Delivery System in Adults With Type 1 Diabetes and Gastroparesis

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 34 (estimated)
• Sponsor: Viral N. Shah · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.

Conditions

• Type 1 Diabetes
• Gastroparesis Due to Diabetes Mellitus Type I

Interventions

Type	Name	Description
DEVICE	Medtronic 780G AID	Participants in Medtronic AID treatment group will use it for three months

Timeline

• Start date: 2026-02-09
• Primary completion: 2026-11-01
• Completion: 2026-12-01
• First posted: 2025-12-17
• Last updated: 2026-02-18

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study